Rybelsus 7 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FT4GV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,949
Award facts
- Contract value 100% obligated
- $49,949.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $49,949.47 to AmerisourceBergen Drug Corp for the supply of Rybelsus 7 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete fulfillment requirement under AmerisourceBergen's larger indefinite delivery contract relationship with DLA.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal healthcare systems, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle for this and similar pharmaceutical supply deliveries. The company supplies a comprehensive range of medications and medical products to support military healthcare programs and other federal medical procurement needs. Rybelsus, a diabetes medication, aligns with AmerisourceBergen's existing portfolio of therapeutic products delivered through DLA's medical supply chain, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FT4GV?
SPE2DR26FT4GV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FT4GV worth?
The government has obligated $49,949 on SPE2DR26FT4GV.
Is contract SPE2DR26FT4GV an order under another contract?
Yes. SPE2DR26FT4GV is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4GV competed?
The extent of competition for SPE2DR26FT4GV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award